Your browser doesn't support javascript.
loading
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Zhang, Liansheng; Zheng, Changcheng; Shen, Xuliang; Hu, Qi; Liu, Jing; Jin, Jie; Luo, Jianmin; Zeng, Yun; Gao, Sujun; Zhang, Xiaohui; Zhou, Xin; Shi, Qingzhi; Xia, Ruixiang; Xie, Xiaobao; Jiang, Zhongxing; Gao, Li; Bai, Yuansong; Li, Yan; Xiong, Junye; Li, Runzi; Zou, Jianjun; Niu, Ting; Yang, Renchi; Hu, Yu.
Afiliación
  • Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.
  • Liu X; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Dis
  • Li Y; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Zhou H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Feng Y; Department of Hematopathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Gao G; The Blood Internal Medicine, The First Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Cheng P; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Huang R; Hematology Department, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yang L; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Hu J; Fujian Medical University Union Hospital, Fuzhou, China.
  • Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
  • Yao Y; Hematology Department, Baoji Central Hospital, Baoji, China.
  • Liu L; Department of Hematopathology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Wang Y; Department of Hematopathology, Shaanxi Provincial People's Hospital, Xi'an, China.
  • Wu D; Hematology Department, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang L; Hematology Department, Lanzhou University Second Hospital, Lanzhou, China.
  • Zheng C; Hematology Department, The First Affiliated Hospital of USTC, Hefei, China.
  • Shen X; Department of Hematology, Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China.
  • Hu Q; Department of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
  • Liu J; The Third Xiangya Hospital of Central South University, Changsha, China.
  • Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
  • Luo J; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zeng Y; Department of Hematology, First Affiliated Hospital of Kunming Medical University, KunMing, China.
  • Gao S; The First Hospital of Jilin University, Changchun, China.
  • Zhang X; Department of Hematology, Peking University People's Hospital, Beijing, China.
  • Zhou X; Hematology Department, Wuxi People's Hospital, Wuxi, China.
  • Shi Q; Hematology Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Xia R; Hematology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xie X; Hematology Department, The First People's Hospital of Changzhou, Changzhou, China.
  • Jiang Z; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Gao L; Department of Hematology, The Second Affiliated Hospital of Military Medical University PLA, Chongqing, China.
  • Bai Y; Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Li Y; Hematology Department, The First Hospital of China Medical University, Shenyang, China.
  • Xiong J; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
  • Li R; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
  • Zou J; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
  • Niu T; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. dr_huyu@126.com.
  • Yang R; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Dis
  • Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. tingniu@sina.com.
J Hematol Oncol ; 14(1): 37, 2021 02 25.
Article en En | MEDLINE | ID: mdl-33632264
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / Pirazolonas / Receptores de Trombopoyetina / Hidrazonas Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / Pirazolonas / Receptores de Trombopoyetina / Hidrazonas Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido